Trial · NCT00423670
Adverse events1,680
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 1,680
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | ANAEMIA | Blood and lymphatic system disorders | PEG +RBV for 48 Wks (Part I) | 35 | 104 | 55 |
| other | ANAEMIA | Blood and lymphatic system disorders | PEG + RBV + BOC for 28 Wks (Part I) | 59 | 107 | 96 |
| other | ANAEMIA | Blood and lymphatic system disorders | PEG + RBV + BOC (From Wk 4) for 24 Wks (Part I) | 55 | 103 | 80 |
| other | ANAEMIA | Blood and lymphatic system disorders | PEG +RBV + BOC for 48 Wks (Part I) | 54 | 103 | 79 |
| other | ANAEMIA | Blood and lymphatic system disorders | PEG + RBV + BOC (From Wk 4) for 44 Wks (Part I) | 58 | 103 | 88 |
| other | ANAEMIA | Blood and lymphatic system disorders | PEG + RBV + BOC for 48 Wks (Part II) | 10 | 16 | 22 |
| other | ANAEMIA | Blood and lymphatic system disorders | PEG +Low-dose RBV + BOC for 48 Wks (Part II) | 14 | 59 | 39 |
| other | ANAEMIA | Blood and lymphatic system disorders | PEG + RBV + BOC (From Wk 24) for 48 Wks (Part I) | 13 | 36 | 13 |
| other | LEUKOPENIA | Blood and lymphatic system disorders | PEG +RBV for 48 Wks (Part I) | 6 | 104 | 15 |
| other | LEUKOPENIA | Blood and lymphatic system disorders | PEG + RBV + BOC for 28 Wks (Part I) | 7 | 107 | 37 |
| other | LEUKOPENIA | Blood and lymphatic system disorders | PEG + RBV + BOC (From Wk 4) for 24 Wks (Part I) | 5 | 103 | 12 |
| other | LEUKOPENIA | Blood and lymphatic system disorders | PEG +RBV + BOC for 48 Wks (Part I) | 5 | 103 | 9 |
| other | LEUKOPENIA | Blood and lymphatic system disorders | PEG + RBV + BOC (From Wk 4) for 44 Wks (Part I) | 8 | 103 | 12 |
| other | LEUKOPENIA | Blood and lymphatic system disorders | PEG + RBV + BOC for 48 Wks (Part II) | 1 | 16 | 7 |
| other | LEUKOPENIA | Blood and lymphatic system disorders | PEG +Low-dose RBV + BOC for 48 Wks (Part II) | 9 | 59 | 58 |
| other | LEUKOPENIA | Blood and lymphatic system disorders | PEG + RBV + BOC (From Wk 24) for 48 Wks (Part I) | 1 | 36 | 2 |
| other | LYMPHADENOPATHY | Blood and lymphatic system disorders | PEG +RBV for 48 Wks (Part I) | 0 | 104 | 0 |
| other | LYMPHADENOPATHY | Blood and lymphatic system disorders | PEG + RBV + BOC for 28 Wks (Part I) | 2 | 107 | 2 |
| other | LYMPHADENOPATHY | Blood and lymphatic system disorders | PEG + RBV + BOC (From Wk 4) for 24 Wks (Part I) | 0 | 103 | 0 |
| other | LYMPHADENOPATHY | Blood and lymphatic system disorders | PEG +RBV + BOC for 48 Wks (Part I) | 0 | 103 | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00423670/events